MedTrace Logo

Safety of Oral Immunotherapy for Cow's Milk Allergy in School-aged Children

NCT01361347 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2017-01-04

No results posted yet for this study

Summary

The purpose of this study is to study the number of Participants with Adverse Events as a Measure of Safety and Tolerability.

Conditions

Interventions

DIETARY_SUPPLEMENT

milk

milk for milk allergic children (1:25 dilution, whole milk)

Sponsors & Collaborators

  • Tampere University Hospital

    lead OTHER

Principal Investigators

  • Marita Paassilta, MD, PhD · Consultant Pediatric Allergist

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01361347 on ClinicalTrials.gov